Vision Loss: These Treatments May Help

     Optic neuritis is characterized by inflammation and destruction of nerve tissue in the eye. Persons with multiple sclerosis (MS) are likely to experience this condition. Optic neuritis may also be the first sign of MS, however not all persons who are affected by the condition will be diagnosed with MS. Women are more likely than men to develop optic neuritis, and the condition typically affects persons between the ages of 20 and 40 years. Signs and symptoms of the condition include eye pain and vision loss, usually in one eye. An abnormality of the immune system and genetics may also play a role.

     Vision typically improves in several weeks without treatment. Methylprednisolone is a corticosteroid that can be administered intravenously for treatment of optic neuritis. If an MRI reveals a high risk of developing
MS, immunomodulator medications may be prescribed. Avonex, a type of interferon beta-1a, is a medication that is injected into the muscle once per week, which may reduce the risk of developing MS. Rebif, another
type of interferon beta-1a, is also prescribed for the treatment of MS. This medication is injected subcutaneously three times a week. Glatiramer acetate (Copaxone) is another type of immunomodulator for treatment and prevention of MS. This medication is also injected subcutaneously.